Change of Directors’ Interest: Appendix 3Y
190329_Directors Interest
Phase I Monepantel Tablets Demonstrate High Safety
190326_Scaled tablet single dose safety performance (clean)
Top 20 Shareholders, March 2019
PAA Top 20 as at 260319
PharmAust Raises $1.3m in Rights Issue
190322_Rights Issue Raises 1.3m
Monepantel Tablets Positive Performance in Phase I
190314_PhaseI part A
Intellectual Property Update
190305_Intellectual Property Update
Appendix 4D and Financial Report
190301_Appendix-4D-and-Financial-Report
Top 20 Shareholders, March 1
190301_Top_20 Shareholders March 1
Offer Document – Rights Issue
190227_Offer_Document
Phase I in Dogs Commences using New Monepantel Tablets
190220_Phase I starts